Jürgen C. Becker

发表

Vitiligo and melanoma‐associated hypopigmentation (MAH):shared and discriminative features

E. Bröcker, H. Hamm, A. Hartmann, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Identification of epigenetically regulated genes distinguishing intracranial from extracranial melanoma metastases.

E. Schröck, D. Aust, D. Schrimpf, 2023, The Journal of investigative dermatology.

S2k Guideline – Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – Update 2022

S. Ugurel, P. Schlattmann, M. Flaig, 2023, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Brief S2k guidelines – Merkel cell carcinoma

S. Reske, D. Vordermark, C. Assaf, 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

A member of the melanoma antigen‐encoding gene (MAGE) family is expressed in human skin during wound healing

J. Becker, E. Bröcker, R. Gillitzer, 1994, International journal of cancer.

Primary cutaneous diffuse large B‐cell lymphoma, leg‐type, treated with a modified R‐CHOP immunochemotherapy – diagnostic and therapeutic challenges

J. Becker, E. Bröcker, M. Wobser, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – long version of the update 2023

M. Weichenthal, A. Hauschild, M. Flaig, 2023, EJC Skin Cancer.

Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy

Eva B. Bröcker, J. Becker, S. Ugurel, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

New therapeutic approaches for solid tumors: Histone deacetylase, methyltransferase and proteasome inhibitors

S. Ugurel, E. Bröcker, D. Schrama, 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Characterisation and outcome of RAC1 mutated melanoma.

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, European journal of cancer.

Lack of clinical efficacy of imatinib in metastatic melanoma

D. Schadendorf, J. Becker, S. Ugurel, 2005, British Journal of Cancer.

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

L Edler, W Rittgen, A. Enk, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021

M. Weichenthal, U. Wehkamp, C. Klemke, 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

S2k guideline: HPV‐associated lesions of the external genital region and the anus – anogenital warts and precancerous lesions of the vulva, the penis, and the peri‐ and intra‐anal skin (short version)

D. Mestel, K. Sotlar, M. Wiese-Posselt, 2018 .

Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.

J. Becker, E. Bröcker, P. Terheyden, 2000, Melanoma research.

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

J. Becker, E. Bröcker, C. Vetter, 2004, British Journal of Cancer.

Treatment of advanced cutaneous T‐cell lymphomas with non‐pegylated liposomal doxorubicin – Consensus of the lymphoma group of the Working Group Dermatologic Oncology

M. Weichenthal, J. Becker, C. Klemke, 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Lichen planus associated with Becker's nevus.

J. Becker, E. Bröcker, P. Terheyden, 1998, Journal of the American Academy of Dermatology.

Vitiligo and melanoma‐associated hypopigmentation (MAH):shared and discriminative features

E. Bröcker, H. Hamm, A. Hartmann, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Classical chemotherapy for metastatic melanoma

E. Bröcker, E. Kämpgen, E Bröcker, 2000, Clinical and experimental dermatology.

Characterisation and outcome of RAC1 mutated melanoma.

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, European journal of cancer.

D. Mestel, K. Sotlar, M. Wiese-Posselt, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

J. Utikal, A. Hauschild, S. Haferkamp, 2023, The Lancet.